A carregar...
Rapamycin versus Methotrexate in Early Diffuse Systemic Sclerosis: Results from a Randomized, Single-blind Pilot Study
OBJECTIVE: To assess the safety and efficacy of rapamycin (RAPA) in the treatment of diffuse systemic sclerosis (SSc) METHODS: Eighteen patients with ≤5 years of diffuse SSc were randomized to receive RAPA or methotrexate (MTX) in a single-blind, 48-week study. Abnormalities in clinical and laborato...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2841149/ https://ncbi.nlm.nih.gov/pubmed/19950289 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.24986 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|